BTC
BTC HEALTH FPO [BTC]
Healthcare · ASX Small Cap
$0.0630 +0.0%
Updated 7 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -11First seen: 2026-02-25
Score Breakdown
Technical62
Catalyst50
Sentiment50
Fundamental61
Momentum60
Risk Gate40
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Sustained volume spike (8.1x median) on DOWN trend
- Near support level (potential bounce)
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Strong cash runway (16 quarters)
- Very high P/S ratio (6855.3x)
- Revenue in sharp decline (-89%)
- Small-cap ($20-100M)
- CANSLIM A: Turned profitable
- CANSLIM I: Institutional ownership (35%)
- Positive 12-1 momentum (+24%)
- Earnings momentum: 2 consecutive improvements
- Liquidity risk: 9 zero-volume days in last 20
- RBA hiking (-3pts)
Risk Signals
- Price below MAs (downtrend)
- Piotroski F-Score weak (3/9, low-confidence approx)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-89%)
- Overseas neutral (-3pts, S&P500 neutral, VIX 27)
Recent Catalysts
LOW BTC Investor Presentation - February 2026
NONE BTC Shareholder Update - February 2026
NONE Half-Year Financial Report & Appendix 4D - 31 December 2025
NONE BTC secures distribution rights for Jafron products
Recent ASX Announcements
| 2026-02-19 | BTC Investor Presentation - February 2026 PRICE SENSITIVE |
| 2026-02-19 | BTC Shareholder Update - February 2026 PRICE SENSITIVE |
| 2026-02-19 | Half-Year Financial Report & Appendix 4D - 31 December 2025 PRICE SENSITIVE |
| 2026-02-13 | BTC secures distribution rights for Jafron products PRICE SENSITIVE |
| 2026-02-13 | Net Tangible Asset Backing - 31 January 2026 |
Key Metrics
$22.5M
Market Cap
27K
Avg Volume
8.1x
Vol Ratio
$0.05 — $0.07
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-9.9%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | insufficient_data | Float: 0% |
| L | Leader vs Laggard | pass | RS: 3 |
| I | Institutional Sponsorship | pass | Inst: 35% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #70 of 122 · Sector avg: 43
View all Healthcare signals →